| LLY | 18.98% | 762.95 | -5.59% | 115,038 | |
| JNJ | 10.83% | 168.11 | +1.14% | 317,120 | |
| NVO | 7.70% | 53.94 | -21.83% | 529,133 | |
| NVS | 7.27% | 117.22 | +0.90% | 304,075 | |
| MRK | 6.14% | 82.63 | -1.70% | 357,084 | |
| SNY | 4.60% | 49.35 | -0.26% | 450,020 | |
| PFE | 4.60% | 24.30 | -0.04% | 913,643 | |
| ABBV | 4.51% | 191.22 | +1.43% | 116,791 | |
| MCK | 4.50% | 712.15 | +0.83% | 31,170 | |
| AZN | 4.47% | 73.98 | +2.99% | 303,315 |
VanEck ETF Trust - VanEck Pharmaceutical ETF is an exchange traded fund launched and managed by Van Eck Associates Corporation. The fund invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the MVIS US Listed Pharmaceutical 25 Index, by using full replication technique. VanEck ETF Trust - VanEck Pharmaceutical ETF was formed on February 1, 2000 and is domiciled in the United States.